BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32070224)

  • 1. APOE-ε4 Genotype and Dementia Before and After Transient Ischemic Attack and Stroke: Population-Based Cohort Study.
    Pendlebury ST; Poole D; Burgess A; Duerden J; Rothwell PM;
    Stroke; 2020 Mar; 51(3):751-758. PubMed ID: 32070224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study.
    Pendlebury ST; Rothwell PM;
    Lancet Neurol; 2019 Mar; 18(3):248-258. PubMed ID: 30784556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of Chronic Kidney Disease With Dementia Before and After TIA and Stroke: Population-Based Cohort Study.
    Kelly DM; Pendlebury ST; Rothwell PM
    Neurology; 2022 Feb; 98(7):e711-e720. PubMed ID: 34996878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodological factors in determining rates of dementia in transient ischemic attack and stroke: (I) impact of baseline selection bias.
    Pendlebury ST; Chen PJ; Bull L; Silver L; Mehta Z; Rothwell PM;
    Stroke; 2015 Mar; 46(3):641-6. PubMed ID: 25657179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apolipoprotein E genotype and cerebrovascular alterations can influence conversion to dementia in patients with mild cognitive impairment.
    Viticchi G; Falsetti L; Vernieri F; Altamura C; Altavilla R; Luzzi S; Bartolini M; Provinciali L; Silvestrini M
    J Alzheimers Dis; 2014; 41(2):401-10. PubMed ID: 24625799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of APOE ε4 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study.
    Gharbi-Meliani A; Dugravot A; Sabia S; Regy M; Fayosse A; Schnitzler A; Kivimäki M; Singh-Manoux A; Dumurgier J
    Alzheimers Res Ther; 2021 Jan; 13(1):5. PubMed ID: 33397450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A large ApoE ε4/ε4 homozygous cohort reveals no association with Parkinson's disease.
    Multhammer M; Michels A; Zintl M; Mendoza MC; Klünemann HH
    Acta Neurol Belg; 2014 Mar; 114(1):25-31. PubMed ID: 23794363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.
    Myers RH; Schaefer EJ; Wilson PW; D'Agostino R; Ordovas JM; Espino A; Au R; White RF; Knoefel JE; Cobb JL; McNulty KA; Beiser A; Wolf PA
    Neurology; 1996 Mar; 46(3):673-7. PubMed ID: 8618665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation.
    Slooter AJ; Tang MX; van Duijn CM; Stern Y; Ott A; Bell K; Breteler MM; Van Broeckhoven C; Tatemichi TK; Tycko B; Hofman A; Mayeux R
    JAMA; 1997 Mar; 277(10):818-21. PubMed ID: 9052712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of dementia in relation to stroke and the apolipoprotein E epsilon4 allele in the very old. Findings from a population-based longitudinal study.
    Zhu L; Fratiglioni L; Guo Z; Basun H; Corder EH; Winblad B; Viitanen M
    Stroke; 2000 Jan; 31(1):53-60. PubMed ID: 10625715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of APOE epsilon2/epsilon3/epsilon4 and promoter gene variants with dementia but not cardiovascular mortality in old age.
    Heijmans BT; Slagboom PE; Gussekloo J; Droog S; Lagaay AM; Kluft C; Knook DL; Westendorp RG
    Am J Med Genet; 2002 Jan; 107(3):201-8. PubMed ID: 11807900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The APOE epsilon4 allele is associated with decline on delayed recall performance in community-dwelling older adults.
    O'Hara R; Yesavage JA; Kraemer HC; Mauricio M; Friedman LF; Murphy GM
    J Am Geriatr Soc; 1998 Dec; 46(12):1493-8. PubMed ID: 9848808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between ApoE epsilon4 and cognitive impairment after stroke.
    Wagle J; Farner L; Flekkøy K; Wyller TB; Sandvik L; Eiklid KL; Fure B; Stensrød B; Engedal K
    Dement Geriatr Cogn Disord; 2009; 27(6):525-33. PubMed ID: 19494491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E ε4 allele is associated with vascular cognitive impairment no dementia in Chinese population.
    Han Y; Zhou A; Li F; Wang Q; Xu L; Jia J
    J Neurol Sci; 2020 Feb; 409():116606. PubMed ID: 31865187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.
    Farrer LA; Cupples LA; Haines JL; Hyman B; Kukull WA; Mayeux R; Myers RH; Pericak-Vance MA; Risch N; van Duijn CM
    JAMA; 1997 Oct 22-29; 278(16):1349-56. PubMed ID: 9343467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
    Klages JD; Fisk JD; Rockwood K
    Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction with the MAPT H1H1 Genotype Increases Dementia Risk in APOE ε4 Carriers in a Population of Southern India.
    Jairani PS; Aswathy PM; Gopala S; Verghese J; Mathuranath PS
    Dement Geriatr Cogn Disord; 2016; 42(5-6):255-264. PubMed ID: 27705964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of
    Qian J; Betensky RA; Hyman BT; Serrano-Pozo A
    Neurology; 2021 May; 96(19):e2414-e2428. PubMed ID: 33771840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.